About this Study Set
This study set covers Health Tech through
12 practice questions.
Exploring the current market trends and economic shifts within Canada's dynamic health technology, pharmaceutical, and digital health sectors. Every question includes the correct answer so you can learn as you go — pick any format above to get started.
Questions & Answers
Browse all 12 questions from the
Canada's Health Tech Boom: AI, Telehealth, and Pharma Market Shifts Unveiled study set below.
Each question shows the correct answer — select a study format above to practice interactively.
1
In 2024, what was the projected revenue for the Canadian telehealth market, and what is its expected Compound Annual Growth Rate (CAGR) through 2030?
-
A
USD 13,514.2 million with a CAGR of 21.3%
-
B
USD 3,057.68 billion with a CAGR of 21.83%
-
C
USD 4,878.1 million with a CAGR of 19.6%
-
D
USD 146.2 billion with a CAGR of 21.63%
2
According to Pender Ventures' 2025 report, what was the approximate total venture funding for Canadian health tech in 2024, and what was the percentage decrease compared to 2023?
-
A
$1.3 billion, a 10% decrease
-
B
$700 million, an 18% decrease
-
C
$1.57 billion, a 5% increase
-
D
$894 million, a 15% decrease
3
What percentage of Canada's pharmaceutical sales represented the global market in 2024, and what was the estimated total expenditure on drugs in Canada for the same year?
-
A
1.5% of global sales; $40.58 billion expenditure
-
B
2.2% of global sales; $43.7 billion expenditure
-
C
3.0% of global sales; $51.56 billion expenditure
-
D
1.8% of global sales; $32.88 billion expenditure
4
In 2024, what was the revenue generated by the Canada healthcare analytics market, and what is its projected CAGR from 2025 to 2033?
-
A
USD 2,776.6 million with a CAGR of 16.2%
-
B
USD 7,416.0 million with a CAGR of 14.6%
-
C
USD 163.80 million with a CAGR of 36.81%
-
D
USD 10.06 billion with a CAGR of 5.5%
5
As of December 2025, what was the total VC investment in Canadian life sciences companies for 2024, and what percentage of this funding went to the Drug Discovery sector?
-
A
$1.38 billion total investment; 12% to Drug Discovery
-
B
$1.57 billion total investment; 10% to Drug Discovery
-
C
$700 million total investment; 28% to Drug Discovery
-
D
$847 million total investment; 33% to Drug Discovery
6
What proportion of Canadians possess at least one wearable device, and what is the projected market value of Canada's digital health market by 2033?
-
A
30% of Canadians; USD 19.5 billion by 2033
-
B
40% of Canadians; USD 106.5 billion by 2033
-
C
50% of Canadians; USD 42.1 billion by 2033
-
D
25% of Canadians; USD 17.0 billion by 2033
7
In 2024, what was the estimated value of Canada's medical devices market (excluding in vitro diagnostics), and what percentage did it represent of the global market?
-
A
USD 10.06 billion, 2.5% of global market
-
B
USD 555.7 billion, 10% of global market
-
C
USD 9.47 billion, 2.3% of global market
-
D
USD 6.6 billion, 1.5% of global market
8
What percentage of Canada's medical device exports were destined for the United States in 2024?
9
In the fiscal year 2024-2025, how many new drug shortage reports were submitted in Canada, and what was the total number of active (un-resolved or anticipated) drug shortages at the end of that period?
-
A
2,588 new reports; 1,772 active shortages
-
B
1,439 new reports; 69 active shortages
-
C
69 new reports; 51 active shortages
-
D
59 new reports; 421 active shortages
10
What was the total investment committed by DIGITAL (Canada's Global Innovation Cluster for Digital Technologies) in health projects by the end of the 2024/25 fiscal year, and what was the total investment from DIGITAL and its partners combined?
-
A
$182 million in health projects; $783 million total
-
B
$432 million in health projects; $1.6 billion total
-
C
$324 million in health projects; $783 million total
-
D
$324 million in health projects; $1.6 billion total
11
As of early 2025, approximately how many healthcare professionals in Canada had electronic access to comprehensive patient information through provincial and territorial systems?
-
A
Over 150,000
-
B
Over 310,000
-
C
Over 500,000
-
D
Over 10,000
12
In 2024, which segment led the Canadian pharmaceutical market by revenue, and what was its approximate market share?
-
A
Conventional drugs (small molecules); 54.7%
-
B
Prescription drugs; not specified
-
C
Cancer treatments; 18.1%
-
D
Hospitals; not specified
